Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

NCT02186847 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02186847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02186847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC
Lead sponsor
NRG Oncology
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2014
Completion date
September 4, 2025
Enrollment
170 (actual)
Sites
223

Conditions

As the registry lists them; a condition with its own page is linked.

adenosquamous lung carcinoma, bronchioloalveolar carcinoma, large cell lung carcinoma, lung adenocarcinoma, non-small cell lung carcinoma, recurrent non-small cell lung carcinoma, squamous cell lung carcinoma, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer